Comera Life Sciences Holdings, Inc.
OTC: CMRA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael G. Campbell
- Employees
- 12
- Headquarters
- Woburn, United States
- IPO year
- 2020
- Market cap
- $3.1K
- Website
- https://comeralifesciences.com
Loading CMRA…
Loading profile data…Frequently asked questions about CMRA
What does Comera Life Sciences Holdings, Inc. (CMRA) do?
Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progr...
Where does CMRA trade?
Comera Life Sciences Holdings, Inc. (CMRA) trades on the Other OTC.
What sector is CMRA in?
Comera Life Sciences Holdings, Inc. (CMRA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Comera Life Sciences Holdings, Inc.?
Michael G. Campbell is the chief executive officer of Comera Life Sciences Holdings, Inc. (CMRA).
Where is Comera Life Sciences Holdings, Inc. headquartered?
Comera Life Sciences Holdings, Inc. is headquartered in United States.
Does CMRA pay a dividend?
Comera Life Sciences Holdings, Inc. (CMRA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CMRA go public?
Comera Life Sciences Holdings, Inc. (CMRA) completed its initial public offering in 2020.